About MS References
MS Society FAQs are based on published, scientific evidence. The references below give details of the research papers and publications that have informed the About MS FAQs.
D Barnes, RA Hughes, RW Morris et al. (1997) Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet, vol 349, pages 902-6
A Compston. (1997) Genetic epidemiology of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, vol 62(6), pages 553-61
A Compston, A Coles. (2002) Multiple sclerosis. The Lancet, vol 359, pages 1221-31
M Finlayson. (2004) Concerns about the future among older adults with multiple sclerosis. American Journal of Occupational Therapy, vol 58(1), pages 54-63
RE Gonsette. (2004). A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis. Expert Opinion on Pharmacotherapy, vol 5(4), pages 747-65
C Lucchinetti, W Bruck. (2004) The pathology of primary progressive multiple sclerosis. Multiple Sclerosis, vol 10, supplement 1, pages S23-30
WI McDonald, A Compston, G Edan et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology, vol 50, pages 121-7
AE Miller. (2001) Clinical features. In SD Cook, Handbook of multiple sclerosis. 3rd ed. New York: Marcel Dekker, pages 231-2
NICE Clinical Guideline 8. Multiple Sclerosis: Management of multiple sclerosis in primary and secondary care, National Institute for Clinical Excellence, London, 2003
P O’Connor. (2002) Key issues in the diagnosis and treatment of multiple sclerosis. Neurology, vol 59, supplement 6, pages 1-33
AD Sadovnick, K Eisen, SA Hashimoto et al. (1995) Pregnancy and multiple sclerosis. A prospective study. Archives of Neurology, vol 52(9), pages 849-50
O Stuve, M Kita, D Pelletier et al. (2004) Mitoxantrone as a potential therapy for primary progressive multiple sclerosis. Multiple Sclerosis, vol 10, supplement 1, pages S58-61
AJ Thompson, CH Polman, DH Miller et al. (1997) Primary progressive multiple sclerosis. Brain, vol 120, pages 1085-96
HL Tremlett, DK Luscombe, CM Wiles. (1998) Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom. Journal of Neurology, Neurosurgery and Psychiatry, vol 65(3), pages 362-5
A Compston. (1997) Genetic epidemiology of multiple sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, vol 62(6), pages 553-61
A Compston, A Coles. (2002) Multiple sclerosis. The Lancet, vol 359, pages 1221-31
M Finlayson. (2004) Concerns about the future among older adults with multiple sclerosis. American Journal of Occupational Therapy, vol 58(1), pages 54-63
RE Gonsette. (2004). A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis. Expert Opinion on Pharmacotherapy, vol 5(4), pages 747-65
C Lucchinetti, W Bruck. (2004) The pathology of primary progressive multiple sclerosis. Multiple Sclerosis, vol 10, supplement 1, pages S23-30
WI McDonald, A Compston, G Edan et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology, vol 50, pages 121-7
AE Miller. (2001) Clinical features. In SD Cook, Handbook of multiple sclerosis. 3rd ed. New York: Marcel Dekker, pages 231-2
NICE Clinical Guideline 8. Multiple Sclerosis: Management of multiple sclerosis in primary and secondary care, National Institute for Clinical Excellence, London, 2003
P O’Connor. (2002) Key issues in the diagnosis and treatment of multiple sclerosis. Neurology, vol 59, supplement 6, pages 1-33
AD Sadovnick, K Eisen, SA Hashimoto et al. (1995) Pregnancy and multiple sclerosis. A prospective study. Archives of Neurology, vol 52(9), pages 849-50
O Stuve, M Kita, D Pelletier et al. (2004) Mitoxantrone as a potential therapy for primary progressive multiple sclerosis. Multiple Sclerosis, vol 10, supplement 1, pages S58-61
AJ Thompson, CH Polman, DH Miller et al. (1997) Primary progressive multiple sclerosis. Brain, vol 120, pages 1085-96
HL Tremlett, DK Luscombe, CM Wiles. (1998) Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom. Journal of Neurology, Neurosurgery and Psychiatry, vol 65(3), pages 362-5
